Skip to content

Role of Homoeopathic treatment in children with Conduct disorder

ROLE OF INDIVIDUALISED HOMOEOPATHIC MEDICINES IN THE MANAGEMENT OF CONDUCT DISORDER IN PAEDIATRIC AGE GROUP: A PROSPECTIVE SINGLE ARM PRE-POST ASSESSMENT INTERVENTIONAL STUDY - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099969
Enrollment
40
Registered
2025-12-31
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F919- Conduct disorder, unspecified

Interventions

Intervention1: Medicine: Individualised Homoeopathic medicine. Oral administration of single dose of individualised Homoeopathic medicine with repeated at fixed interval of time depending as required

Sponsors

National institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cases satisfying Conduct disorder diagnostic criteria of DSM 5 Participants or parents who are willing to give written informed consent to participate in the study and to give verbal or written assent Participants pr parents / guardians who can read or write or understand either English or Hindi or Bengali languages

Exclusion criteria

Exclusion criteria: Children and adolescents suffering from violent and complicated conditions Diagnosed cases of other major Psychiatric conditions such as Oppositional Defiant Disorder, ADHD, ASD, Mental retardation, Mood disorders, Intermittent explosive disorders, substance use disorders Cases with special learning disorder and adjust disorders Other serious systemic diseases including genetic conditions

Design outcomes

Primary

MeasureTime frame
Change in the mean score of Conduct Disorder and Oppositional Defiant Disorder Scale in managing the Conduct disorder in pediatric age group after 6 months of individualised Homoeopathic medicineTimepoint: Baseline and 6 months

Secondary

MeasureTime frame
1. To evaluate the changes in the MONARCH scale after of individualized Homoeopathic medicine. 2. To evaluate any Adverse Drug Reaction (ADR) or Adverse Drug Events (ADE) using Adverse Drug Reaction probability scoreTimepoint: Baseline and 6 months

Countries

India

Contacts

Public ContactDr Kalasapakam Vijay Ananth

National Institute of Homoeopathy

vjananth74@gmail.com8584888058

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026